Bellevue Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,200
| Closed | -$321K | – | 168 |
|
|
2024
Q4 | $321K | Hold |
8,200
| – | – | 0.01% | 134 |
|
|
2024
Q3 | $323K | Sell |
8,200
-2,000
| -20% | -$78.7K | 0.01% | 137 |
|
|
2024
Q2 | $398K | Sell |
10,200
-3,900
| -28% | -$152K | 0.01% | 134 |
|
|
2024
Q1 | $607K | Sell |
14,100
-7,900
| -36% | -$340K | 0.01% | 126 |
|
|
2023
Q4 | $1.01M | Sell |
22,000
-1,900
| -8% | -$87.5K | 0.02% | 121 |
|
|
2023
Q3 | $816K | Hold |
23,900
| – | – | 0.01% | 135 |
|
|
2023
Q2 | $920K | Buy |
+23,900
| New | +$920K | 0.01% | 131 |
|